RASA2 and neoplasm: The RAS p21 protein activator 2 (RASA2) gene identified in our study encodes a protein that has been previously demonstrated to serve as a tumor suppressor in melanoma, and therefore, mutations affecting RASA2 might be associated with uncontrolled inflammation [81].